The Threats of Treatment-Resistant Depression

There are advanced phase three trials in Europe using psilocybin for treatment-resistant depression. In the United States, there was a phase three trial going on under the auspices of the FDA testing the potential for MDMA, Molly or ecstasy in treating treatment-resistant PTSD. The more connected we can be as humans, the better off we are," says John Sutter.